Morningstar
•
Aug 05, 2026
Elanco Animal Health Incorporated: Elanco Earnings: Continued Strength in Key New Products Supports Strong Quarter
Summary
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
DXCM: Lowering target price to $26.00
Sep 02, 2026
•
DXCM, TRUP
AVTR: What does Argus have to say about AVTR?
Sep 02, 2026
•
AVTR
AXTA: Lowering target price to $39.00
Sep 02, 2026
•
AXTA
PEN: Lowering target price to $355.00
Sep 02, 2026
•
PEN
NVST: Lowering target price to $28.00
Sep 02, 2026
•
NVST
